News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
106last 24h
3125last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
Motley Fool1d agoneutral
Forget Lilly and Novo: Pfizer Is Planning a Wave of Phase 3 Obesity TrialsBarchart2d agoneutral
Pfizer vs. AbbVie: Higher Yield and Cheaper Valuation Give One the Clear EdgeSimply Wall St.2d agoneutral
Pfizer (PFE) Maps Out $650 Million Connecticut Center For Global Clinical TrialsACCESS Newswire2d agoneutral
Medicus Pharma Reports Third Quarter 2026 Financial Results and Provides Corporate Update24/7 Wall St.2d agoneutral
Bristol Myers Squibb Yields Over 4%. Can Its Dividend Survive 2027?GuruFocus.com2d agoneutral
Rigel Pharmaceuticals Inc (RIGL) (Q3 2026) Earnings Call Highlights: Record Product Sales of ...24/7 Wall St.2d agoneutral
How to Convert an $840,000 401(k) to a Roth IRA and Collect $4,050 a Month Tax-Free for LifeManufacturing Dive2d agoneutral
Pfizer to build $650M manufacturing technology center in Connecticut24/7 Wall St.3d agoneutral
Are Your Dividends Safe? 4 Companies Whose Debt Is Competing With the PayoutBusiness Wire3d agoneutral
European Enterprises Face Growing Pressure to Turn AI Investment into Business Value, ISG Says